These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 3486919

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP, Cao VV, Fehér J, Gergely P.
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 25. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 26. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH, Liu HW, Lin SF, Chen JR, Chen TP.
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 34. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
    Meryhew NL, Shaver C, Messner RP, Runquist OA.
    J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
    [Abstract] [Full Text] [Related]

  • 35. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
    Schifferli JA, Morris SM, Dash A, Peters DK.
    Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
    [Abstract] [Full Text] [Related]

  • 36. Human platelet-immune complex interaction in plasma.
    Clark WF, Tevaarwerk GJ, Reid BD.
    J Lab Clin Med; 1982 Dec; 100(6):917-31. PubMed ID: 6982951
    [Abstract] [Full Text] [Related]

  • 37. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.
    Lobatto S, Daha MR, Breedveld FC, Pauwels EK, Evers-Schouten JH, Voetman AA, Cats A, Van Es LA.
    Clin Exp Immunol; 1988 Apr; 72(1):55-9. PubMed ID: 3396221
    [Abstract] [Full Text] [Related]

  • 38. Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome.
    Fields TR, Zarrabi MH, Gerardi EN, Bennett RS, Zucker S, Hamburger MI.
    J Rheumatol; 1986 Aug; 13(4):726-31. PubMed ID: 3772920
    [Abstract] [Full Text] [Related]

  • 39. Useful laboratory measurements in the management of systemic lupus erythematosus.
    Morrow WJ, Isenberg DA, Todd-Pokropek A, Parry HF, Snaith ML.
    Q J Med; 1982 Aug; 51(202):125-38. PubMed ID: 6981121
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.